Seminar
Developing new strategies for dendritic cell-based cancer immunotherapy
Dr Ghaith Bakdash
Department of Tumor Immunology, Radboudumc, Netherlands
In his research, Dr Bakdash is developing new strategies for dendritic cell-based cancer immunotherapy. The applied approaches include utilizing the combined effects of different dendritic cell subsets, identifying novel adjuvants and tackling tumor-associated immune suppressive elements.
